PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of thrombjBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleThrombosis JournalJournal Front Page
 
Thromb J. 2010; 8: 13.
Published online 2010 July 21. doi:  10.1186/1477-9560-8-13
PMCID: PMC2915955

Platelet dysfunction and inhibition of multiple electrode platelet aggregometry caused by penicillin

Abstract

Beta-lactam antibiotics, e.g. penicillin, may inhibit platelet function and lead to reduced response in light transmission aggregometry and adhesion. However, influence on platelet function tests more commonly used in clinical practice, such as multiple electrode platelet aggregometry (MEA), have not been described so far. We report a case of a patient with local streptococcus infection. Treatment with penicillin resulted in mild bleeding tendency after 3 days. While coagulation parameters were normal, assessment of platelet function by MEA revealed strong platelet inhibition of both ADP and arachidonic acid induced platelet aggregation comparable to normal responders to antiplatelet therapy. Change of antibiotic regime resulted in recovery of platelet function. Thus, penicillin therapy may impact on platelet function and consecutively commonly used platelet function assays, e.g. MEA.

Case report

Inhibition of platelet function in the presence of beta-lactam antibiotics was first described decades ago. In the first documented report in 1973, Cazenave et al. found that beta-lactam antibiotics (BLA), e.g. penicillin, inhibit all major types of platelet functions in vitro, such as secretion, adhesion and also aggregation [1]. Postulated mechanisms are inhibition of agonist-stimulated platelet calcium influx [2], and impairment of agonist binding to their specific receptors on the platelet surface [3]. Importantly, penicillin binds irreversibly to platelets [4]. This results in a dose- and time-dependent effect of BLA on platelet function in animals and humans, which occurs within 24 to 72 hours after therapy induction [4-6].

A 46-year old female patient presented to our clinic with a perimandibular abscess following surgical removal of a third molar. The patient had no medical therapy upon admission. Despite elevated inflammation parameters other blood tests were normal. The patient was treated with surgical drainage and intravenous penicillin (12 million IU/day) because of local infection with penicillin-sensitive streptococcus species. Due to swelling of the neck and jaw the patient required mechanical ventilation for three days. In addition to antibiotic therapy, the patient received fentanyl and midazolam intravenously for analgo-sedation, and enteral feeding by tube.

On postoperative day 3 bleeding tendency during invasive procedure (routine placement of arterial catheter) was noticed. Platelet counts (174000 [150000-450000]/μl), partial thromboplastin time (PTT 31 [25-39] sec) and international normalized ratio (INR 1.0) were normal. However, multiple electrode platelet aggregometry (MEA)[7] revealed significant inhibition in platelet function in both adenosine diphosphate (ADP) and arachidonic acid (AA) tests (fig. (fig.1).1). In detail, on day 3 MEA area under the curve (AUC) in response to ADP was 250, and 109 in response to AA respectively. In a recent study, MEA results from untreated and clopidogrel naïve subjects were 650.5 AUC [523.0-807.0] at baseline, and application of 600 mg of clopidogrel resulted in a significant reduction to 233.5 AUC [145.0-429.5][8]. Likewise, intravenous application of 500 mg acetylsalicylic acid resulted in mean values of arachidonic acid-induced aggregation (ASPI test) of 137 ± 44 [9]. Thus, the here presented inhibition of ADP- and AA-induced platelet aggregation in the presence of BLA is similar to patients receiving antiplatelet therapy (fig. (fig.11).

Figure 1
Trend in platelet function in relation to penicillin therapy. Platelet function was assessed by multiple electrode platelet aggregometry (AUC) in response to adenosine diphosphate (ADP) and arachidonic acid (AA). Intravenous penicillin therapy (12 million ...

Next, the antibiotic regime was changed to clindamycin and ciprofloxacin. After cessation of penicillin treatment, platelet MEA response increased (fig. (fig.1).1). However, ADP-induced platelet aggregation was still abnormal 4 days after application of the last penicillin dose. Thus, penicillin treatment may lead to significant platelet inhibition, and normalization of platelet function is prolonged due to irreversible binding of penicillin to platelets [4]. Importantly, recovery of platelet function after discontinuation of treatment in vivo normally requires 3 to 7 days [6]. However, cases with abnormal aggregation for more than 2 weeks after cessation of penicillin therapy have been described [6].

In the era of coronary stent placement platelet function assays are widely used to assess platelet function under antiplatelet therapy. MEA is a common test to determine platelet reactivity under treatment with clopidogrel and acetylsalicylic acid, and results closely correlate with light transmission aggregometry [8]. MEA seems to be superior to other platelet function tests, e.g. VASP assay, in the prediction of adverse events such as stent thrombosis [10].

However, patients undergoing percutaneous coronary intervention (PCI) may develop infections of any kind that require medical treatment. Antibiotics are widely prescribed drugs for both in- and outpatient use [11,12]. It is, therefore, tempting to speculate that simultaneous application of antiplatelet drugs and beta-lactam antibiotics leads to significant variations in MEA values. In worst-case scenario, insufficient response to antiplatelet drugs, e.g. clopidogrel, may be disguised by the effect of BLA. Whether a combined treatment with beta-lactam antibiotics and antiplatelet drugs impacts on hemostasis, and whether the validity of commonly used platelet reactivity tests is influenced by BLA should be clarified by future studies. Also, it should be addressed if antiplatelet therapy in individuals with penicillin as a co-medication leads to increased bleeding events, and if in these patients antiplatelet therapy needs to be (temporarily) reduced.

While impairment of platelet function in vivo seems to be a rather common phenomenon in individuals receiving penicillin and also other BLA [4-6,13], occurrence of bleeding secondary to platelet dysfunction may vary [13]. These differences can be attributed to dose-dependent effects of penicillin and a consequence of irreversible binding to platelets [4-6], but also to the type of BLA chosen for treatment [13]. Further, blood serum constituents, e.g. albumin, may influence occurrence of bleeding in patients receiving BLA [14].

In summary, the here described case report suggests that patients under BLA therapy may display disturbed platelet function. As in our case, platelet inhibition can result in a significantly reduced aggregatory response to ADP and AA comparable to normal responders to antiplatelet therapy [15]. Therefore, in some cases it may be indicated to re-evaluate platelet function after discontinuation of BLA treatment.

Consent

Written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

CS designed the study, analyzed data and wrote the manuscript. OvB designed the study and carried out platelet function tests. RO analyzed data. NvB designed the study. SM wrote the manuscript. All authors read and approved the final manuscript.

References

  • Cazenave JP, Packham MA, Guccione MA, Mustard JF. Effects of penicillin G on platelet aggregation, release, and adherence to collagen. Proc Soc Exp Biol Med. 1973;142:159–159. [PubMed]
  • Burroughs SF, Johnson GJ. Beta-lactam antibiotics inhibit agonist-stimulated platelet calcium influx. Thromb Haemost. 1993;69:503–503. [PubMed]
  • Shattil SJ, Bennett JS, McDonough M, Turnbull J. Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with the platelet surface. J Clin Invest. 1980;65:329–329. doi: 10.1172/JCI109676. [PMC free article] [PubMed] [Cross Ref]
  • Burroughs SF, Johnson GJ. Beta-lactam antibiotic-induced platelet dysfunction: evidence for irreversible inhibition of platelet activation in vitro and in vivo after prolonged exposure to penicillin. Blood. 1990;75:1473–1473. [PubMed]
  • Johnson GJ, Rao GH, White JG. Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Studies of the dose-response relationship and mechanism of action in dogs. Am J Pathol. 1978;91:85–85. [PubMed]
  • Brown CH, Natelson EA, Bradshaw W, Williams TW Jr, Alfrey CP Jr. The hemostatic defect produced by carbenicillin. N Engl J Med. 1974;291:265–265. doi: 10.1056/NEJM197408082910601. [PubMed] [Cross Ref]
  • Toth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost. 2006;96:781–781. [PubMed]
  • Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schomig A, Kastrati A, von Beckerath N. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost. 2008;99:121–121. [PubMed]
  • Jambor C, Weber CF, Gerhardt K, Dietrich W, Spannagl M, Heindlz B, Zwissler B. Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction. Anesth Analg. 2009;109:25–25. doi: 10.1213/ane.0b013e3181a27d10. [PubMed] [Cross Ref]
  • Siller-Matula JM, Christ G, Lang IM, Delle-Karth G, Huber K, Jilma B. Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay. J Thromb Haemost. 2010;8:351–351. doi: 10.1111/j.1538-7836.2009.03699.x. [PubMed] [Cross Ref]
  • Lawrence C, Tuma R, Guha S, Michael H, Lowy FD, Shuter J. Multiple antibiotic changes during the first 72 hours of hospitalization. Am J Med Sci. 2001;322:61–61. doi: 10.1097/00000441-200108000-00002. [PubMed] [Cross Ref]
  • Goossens H, Ferech M, Coenen S, Stephens P. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis. 2007;44:1091–1091. doi: 10.1086/512810. [PubMed] [Cross Ref]
  • Weitekamp MR, Caputo GM, Al-Mondhiry HA, Aber RC. The effects of latamoxef, cefotaxime, and cefoperazone on platelet function and coagulation in normal volunteers. J Antimicrob Chemother. 1985;16:95–95. doi: 10.1093/jac/16.1.95. [PubMed] [Cross Ref]
  • Sloand EM, Klein HG, Pastakia KB, Pierce P, Prodouz KN. Effect of albumin on the inhibition of platelet aggregation by beta-lactam antibiotics. Blood. 1992;79:2022–2022. [PubMed]
  • Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schomig A, Kastrati A, von Beckerath N. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol. 2009;53:849–849. doi: 10.1016/j.jacc.2008.11.030. [PubMed] [Cross Ref]

Articles from Thrombosis Journal are provided here courtesy of BioMed Central